RNASeq profiling of COVID19‐infected patients identified an EIF2AK2 inhibitor as a potent SARS‐CoV‐2 antiviral

RNASeq profiling of COVID19‐infected patients identified an EIF2AK2 inhibitor as a potent SARS‐CoV‐2 antiviral

Bibliographic Details
Main Authors: Sidharth Jain, Samantha Rego, Steven Park, Yiran Liu, Simone Parn, Kush Savsani, David S. Perlin, Sivanesan Dakshanamurthy
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Clinical and Translational Medicine
Online Access:https://doi.org/10.1002/ctm2.1098
Description
ISSN:2001-1326

Similar Items